Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of continuing treatment with caffeine
citrate in the hospital and at home in moderately preterm infants with resolved apnea of
prematurity on days of hospitalization after randomization.
Phase:
Phase 3
Details
Lead Sponsor:
NICHD Neonatal Research Network
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)